A Case-Based Look at Healthy Weight Loss for Survivors of Cancer

The AP plays a vital role in helping cancer survivors achieve and maintain a healthy weight. The AP must maintain an accurate knowledge base of the current diet trends and their safety. When considering weight-loss medications or alternative methods as part of a patient’s regimen, the AP must weigh both the risks and the benefits and effectively communicate them to the patient. Counseling, support, and referrals to a registered dietitian are all part of the oncology AP’s role.

• Publication year

  2016

• Venue

  Journal of the Advanced Practitioner in Oncology

• Publication date

  2016-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.6004/jadpro.2016.7.2.8PMID 28090371PMCID 5226314
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• American Society of Clinical Oncology position statement on obesity and cancer.

  2014cited by this paper
• Tolerability and Safety of the New Anti-Obesity Medications

  2014cited by this paper
• The new weight-loss drugs, lorcaserin and phentermine-topiramate: slim pickings?

  2014cited by this paper
• Healthy Weight Loss for the Cancer Survivor

  2014cited by this paper
• New drug therapies for the treatment of overweight and obese patients.

  2013cited by this paper
• Safety of antiobesity drugs

  2013cited by this paper
• Effect of the Human Chorionic Gonadotropin Diet on Patient Outcomes

  2013influential reference
• "There they go again"--hCG and weight loss.

  2011cited by this paper
• Influence of Obesity on the Serum Carcinoembryonic Antigen Value in Patients with Colorectal Cancer

  2010cited by this paper
• Body Mass Index and Risk , Age of Onset , and Survival in Patients With Pancreatic Cancer

  2009cited by this paper
• Pharmacotherapy for obesity.

  2009cited by this paper
• Position of the American Dietetic Association: weight management.

  2009cited by this paper
• Relationship between potentially modifiable lifestyle factors and risk of second primary contralateral breast cancer among women diagnosed with estrogen receptor-positive invasive breast cancer.

  2009cited by this paper
• Obesity and Mortality in Men With Locally Advanced Prostate Cancer: Analysis of RTOG 85-31

  2009cited by this paper
• F1000 highlights

  2009cited by this paper
• Long‐term effectiveness of diet‐plus‐exercise interventions vs. diet‐only interventions for weight loss: a meta‐analysis

  2009cited by this paper
• Obesity and mortality in men with locally advanced prostate cancer

  2007cited by this paper
• Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer.

  2006cited by this paper
• Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer.

  2005cited by this paper
• Cancer Facts & Figures 2004

  2004cited by this paper
• Long-term effectiveness of lifestyle and behavioral weight loss interventions in adults with type 2 diabetes: a meta-analysis.

  2004cited by this paper
• Influence of body mass index on outcomes and treatment‐related toxicity in patients with colon carcinoma

  2003cited by this paper
• Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

  2003cited by this paper
• Pharmacotherapy for obesity.

  2002cited by this paper
• Position of the American Dietetic Association: weight management.

  2002cited by this paper
• Obesity and Cancer Risk

  2001cited by this paper
• Use and Abuse of Appetite-Suppressant Drugs in the Treatment of Obesity

  1993cited by this paper
• Effect of human chorionic gonadotrophin on weight loss, hunger, and feeling of well-being.

  1973cited by this paper

• The Impact and Safety of GLP‐1 Agents and Breast Cancer

  2025cites this paper